Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
New breast cancer research from G. Vonminckwitz et al outlined
May 8th, 2008
According to recent research published in the journal Ejc Supplements, "Neoadjuvant systemic chemotherapy (NST) can effect freedom from locoregional and distant disease, improve surgical options by reducing the extent of required surgery, and provide useful early information on tumour biology and responsiveness to chemotherapy." "Taxane-containing regimens are widely used both as monotherapy and in combination with anthracyclines. However, questions remain regarding choice of agents, optimal treatment duration and whether sequential or simultaneous administration of these agents is best," wrote G. Vonminckwitz and colleagues. The researchers...
Source: Women's Health Weekly (2008-05-08)
|
